| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/16/2013 | US8486392 Methods and compositions for diagnosing and treating diseases |
| 07/16/2013 | US8486391 Cancer treatment kits using antibodies to aminophospholipids |
| 07/16/2013 | CA2660463C Antibodies to il-17a |
| 07/16/2013 | CA2652028C Secreted campylobacter flagella coregulated proteins as immunogens |
| 07/16/2013 | CA2650056C Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 07/16/2013 | CA2591786C Prevention of thrombus formation and/or stabilization |
| 07/16/2013 | CA2551121C Crosslinked hyaluronic acid compositions for tissue augmentation |
| 07/16/2013 | CA2526007C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 07/16/2013 | CA2517181C Methods of producing influenza vaccine compositions |
| 07/16/2013 | CA2512138C Kim-1 antagonists and use to modulate immune system |
| 07/16/2013 | CA2483980C Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 07/16/2013 | CA2478629C Method and apparatus for producing dry particles |
| 07/16/2013 | CA2476890C Subtilisin carlsberg proteins with reduced immunogenicity |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2425486C Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 07/16/2013 | CA2395406C Method for treating inflammation |
| 07/16/2013 | CA2384948C Therapies for chronic renal failure using one or more integrin antagonists |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/16/2013 | CA2330231C Composition and method for modulating dendritic cell-t cell interaction |
| 07/16/2013 | CA2289742C Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 07/16/2013 | CA2226624C Methods for treatment of allergic asthma |
| 07/12/2013 | WO2012094540A2 Methods for preparation of glycosphingolipids and uses thereof |
| 07/12/2013 | CA2854725A1 Methods for preparation of glycosphingolipids and uses thereof |
| 07/11/2013 | WO2013103816A1 Partial mhc constructs and methods of use |
| 07/11/2013 | WO2013103808A1 Expression of negative sense rna viruses and double-stranded rna viruses, and uses thereof |
| 07/11/2013 | WO2013103800A1 Anti-transferrin receptor antibodies and methods using same |
| 07/11/2013 | WO2013103783A1 Murine il-13 antibodies |
| 07/11/2013 | WO2013103658A1 Native and agonist ctl epitopes of the muc1 tumor antigen |
| 07/11/2013 | WO2013103434A1 Methods and compositions to protect aquatic invertebrates from disease |
| 07/11/2013 | WO2013103362A1 Antigen-presenting platelets and methods of eliciting an immune response |
| 07/11/2013 | WO2013103248A1 Myostatin inhibitor comprising extracellular water-soluble domains of dlk1 as active ingredient |
| 07/11/2013 | WO2013102825A1 Cdcp1 and breast cancer |
| 07/11/2013 | WO2013102492A1 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, dna fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application |
| 07/11/2013 | WO2013071056A3 Combination drug therapy for the treatment of solid tumors |
| 07/11/2013 | WO2013049535A3 Influenza vaccine |
| 07/11/2013 | WO2013044177A3 Bacterial strains expressing methylase genes and uses thereof |
| 07/11/2013 | WO2013020090A3 STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM |
| 07/11/2013 | WO2013001369A4 Therapeutic and diagnostic target |
| 07/11/2013 | WO2013001362A3 Contiguous overlapping peptides for treatment of ragweed pollen allergy |
| 07/11/2013 | WO2012139103A3 Slurry velocity reducer |
| 07/11/2013 | WO2012138377A3 The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals |
| 07/11/2013 | US20130179997 Transgenic animal expressing alzheimer's tau protein |
| 07/11/2013 | US20130178418 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 07/11/2013 | US20130178412 Dihydroxyproply-cysteine peptide and agent containing this peptide |
| 07/11/2013 | US20130177627 Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes |
| 07/11/2013 | US20130177625 Immunogenic compositions and methods for treating neoplasia |
| 07/11/2013 | US20130177595 Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 07/11/2013 | US20130177594 Pharmaceutical composition and method for producing the same |
| 07/11/2013 | US20130177593 Personalized site-specific immunomodulation |
| 07/11/2013 | US20130177592 Immunization against clostridium difficile disease |
| 07/11/2013 | US20130177591 Lipid Based Adjuvants for DNA Plasmids |
| 07/11/2013 | US20130177588 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 07/11/2013 | US20130177587 Functional influenza virus-like particles (vlps) |
| 07/11/2013 | US20130177584 Recombinant Polyprotein Vaccines For the Treatment and Diagnosis of Leishmaniasis |
| 07/11/2013 | US20130177583 Molecular clone of hiv-1 |
| 07/11/2013 | US20130177582 Parapoxvirus expressing the vp60 major capsid protein of the rabbit haemorrhagic disease virus |
| 07/11/2013 | US20130177578 Treatment of Metastatic Breast Cancer |
| 07/11/2013 | US20130177576 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions |
| 07/11/2013 | US20130177574 ANTI-HLA CLASS-Ib ANTIBODIES MIMIC IMMUNOREACTIVITY AND IMMUNOMODULATORY FUNCTIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIg) USEFUL AS THERAPEUTIC IVIg MIMETICS AND METHODS OF THEIR USE |
| 07/11/2013 | US20130177571 Anti-Mesothelin Antibodies |
| 07/11/2013 | US20130177565 Administering anti-placental growth factor antibodies |
| 07/11/2013 | US20130177564 Administering anti-placental growth factor antibodies |
| 07/11/2013 | US20130177563 Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells |
| 07/11/2013 | US20130177562 Methods of antagonizing signal transduction in dorsal root ganglion cells |
| 07/11/2013 | US20130177560 Methods of treatment using rage fusion proteins |
| 07/11/2013 | US20130177558 Method of Treating Immunological Disorders by Administering Truncated BAFF Receptors |
| 07/11/2013 | US20130177556 Egfr aptamer inhibitor for use in therapy and diagnosis |
| 07/11/2013 | US20130177554 Neuropilin as a biomarker for bevacizumab combination therapies |
| 07/11/2013 | US20130177552 Methods and compositions for modulating ocular damage |
| 07/11/2013 | US20130177525 Cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 07/11/2013 | US20130177498 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 07/11/2013 | DE112011102640T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung undPrävention von Infektionskrankheiten A pharmaceutical combination composition and methods for treating of infectious diseases undPrävention |
| 07/11/2013 | CA2801319A1 Pharmaceutical composition and method for producing the same |
| 07/10/2013 | EP2612869A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 07/10/2013 | EP2612680A1 Vaccine |
| 07/10/2013 | EP2612679A1 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| 07/10/2013 | EP2612151A1 Biomarkers and methods of treatment |
| 07/10/2013 | EP2612148A1 Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines |
| 07/10/2013 | EP2611833A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs |
| 07/10/2013 | EP2611832A2 Anti-cxcl13 antibodies and methods of using the same |
| 07/10/2013 | EP2611831A1 Treatment of myocardial infarction using tgf - beta antagonists |
| 07/10/2013 | EP2611829A2 Novel antigen binding proteins |
| 07/10/2013 | EP2611827A1 Recombinant t-cell receptor ligands with covalently bound peptides |
| 07/10/2013 | EP2611823A1 Peptide containing multiple n-linked glycosylation sequons |
| 07/10/2013 | EP2611467A1 Small liposomes for delivery of immunogen-encoding rna |
| 07/10/2013 | EP2611465A2 Human immunodeficiency virus (hiv)-neutralizing antibodies |
| 07/10/2013 | EP2611464A2 Novel modulators and methods of use |
| 07/10/2013 | EP2611463A2 Identification and enrichment of cell subpopulations |
| 07/10/2013 | EP2611462A2 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 07/10/2013 | EP2611461A1 Pegylated liposomes for delivery of immunogen-encoding rna |
| 07/10/2013 | EP2611460A1 Newcastle disease virus vectored herpesvirus vaccines |
| 07/10/2013 | EP2611420A2 Lipids suitable for liposomal delivery of protein-coding rna |
| 07/10/2013 | EP2261376B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 07/10/2013 | CN1541109B Inhibitors of HER3 activity |
| 07/10/2013 | CN103201292A Treatment of myocardial infarction using TGF-[beta] antagonists |
| 07/10/2013 | CN103201291A Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same |
| 07/10/2013 | CN103201290A S100a4 antibodies and therapeutic uses thereof |
| 07/10/2013 | CN103201287A Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof |
| 07/10/2013 | CN103200964A Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| 07/10/2013 | CN103200963A Dual variable domain immunoglobulins and uses thereof |